Replimune, which suffered significant losses on July 22, 2025, after the FDA rejected its skin cancer treatment, is one of the top gainers in premarket trading today.
The following is the list of biotech stocks making big moves in premarket trading today.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com